TY  - GEN
AU  - Sarbia,M
AU  - Ott,N
AU  - Pühringer-Oppermann,F
AU  - Brücher,B L D M
TI  - The predictive value of molecular markers (p53, EGFR, ATM, CHK2) in multimodally treated squamous cell carcinoma of the oesophagus
SN  - 0007-0920
PY  - 2008///0116
KW  - Adult
KW  - Aged
KW  - Ataxia Telangiectasia Mutated Proteins
KW  - Biomarkers, Tumor
KW  - analysis
KW  - Biopsy, Needle
KW  - Carcinoma, Squamous Cell
KW  - metabolism
KW  - Cell Cycle Proteins
KW  - Checkpoint Kinase 2
KW  - Cisplatin
KW  - administration & dosage
KW  - Combined Modality Therapy
KW  - DNA-Binding Proteins
KW  - Disease Progression
KW  - Drug Administration Schedule
KW  - ErbB Receptors
KW  - Esophageal Neoplasms
KW  - Female
KW  - Fluorouracil
KW  - Follow-Up Studies
KW  - Humans
KW  - Immunohistochemistry
KW  - Male
KW  - Middle Aged
KW  - Neoadjuvant Therapy
KW  - methods
KW  - Predictive Value of Tests
KW  - Prospective Studies
KW  - Protein Serine-Threonine Kinases
KW  - Remission Induction
KW  - Survival Analysis
KW  - Treatment Outcome
KW  - Tumor Suppressor Protein p53
KW  - Tumor Suppressor Proteins
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1038/sj.bjc.6604037
ER  -